Tuesday, October 18, 2022 4:00:05 PM
“The official end of the NWBio Quiet Period. NWBio will be able to publicly and freely discuss its progress, plans and timing for DCVax-L regulatory submissions in the US, UK, Canada, Germany and the rest of the EU.”
JA does not forbid updates around regulatory submissions. They could do it now or could have done it 6-12 months ago if they wanted to. Let’s face it they haven’t updated us because there is limited progress on the applications per se given other requirements they need to fulfill first. They told us about PIP approval when progress was made. Likewise, they will tell us about commercial manufacturing approval once that comes through. Just remember - they will shout from the roof top as soon as the MAA is accepted regardless of whether the JA is out or not. And we may still be waiting for an official TLD at that point! ;)
JA does not forbid updates around regulatory submissions. They could do it now or could have done it 6-12 months ago if they wanted to. Let’s face it they haven’t updated us because there is limited progress on the applications per se given other requirements they need to fulfill first. They told us about PIP approval when progress was made. Likewise, they will tell us about commercial manufacturing approval once that comes through. Just remember - they will shout from the roof top as soon as the MAA is accepted regardless of whether the JA is out or not. And we may still be waiting for an official TLD at that point! ;)
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
